Hepatitis Screen
Hepatitis A, B, and C screening with immunity check.
An EBV VCA IgG test detects IgG antibodies against the Epstein-Barr virus viral capsid antigen (VCA). A positive result may indicate a past or current EBV infection, as VCA IgG antibodies typically appear during the acute phase and persist for life.
Doctor's Assessment Included
This test detects the presence of IgG antibodies directed against the viral capsid antigen of the Epstein-Barr virus in your blood. VCA IgG antibodies appear early during EBV infection, typically within the first few weeks, and persist indefinitely. The test provides a qualitative result indicating whether these antibodies are present.
VCA IgG testing is an important component of the EBV antibody panel. Since VCA IgG antibodies persist for life, a positive result confirms exposure to EBV at some point. When combined with other EBV markers (VCA IgM, EBNA IgG), it helps healthcare professionals determine the stage of infection. This can be relevant for evaluating symptoms such as chronic fatigue.
Testing may be recommended when investigating symptoms consistent with infectious mononucleosis (such as fatigue, sore throat, swollen lymph nodes), or when assessing EBV exposure status as part of a broader evaluation. Consult a healthcare professional for guidance.
Avoid sharing personal items such as drinking glasses, utensils, and toothbrushes, as EBV spreads through saliva. Maintain a strong immune system through regular exercise, adequate sleep, balanced nutrition, and stress management. If you are experiencing prolonged fatigue or recurrent symptoms, consult a healthcare professional.
These panels measure values from the same category as this marker.
Hepatitis A, B, and C screening with immunity check.
Complete Hepatitis A, B, and C panel.
HIV, Syphilis, and Hepatitis B screening: commonly requested viral and bacterial screenings.
EBV VCA IgG
€36,-